Exploring Gene Expression Signatures for Predicting Disease Free Survival after Resection of Colorectal Cancer Liver Metastases

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Snoeren, Nikol ^a   van Hooff, Sander R ^a   Adam, Rene ^b   van Hillegersberg, Richard ^a   Voest, Emile E ^a   Guettier, Catherine ^b   van Diest, Paul J ^a   Nijkamp, Maarten W ^a   Brok, Mariel O ^a   van Leenen, Dik ^a   Groot Koerkamp, Marian J A ^a   Holstege, Frank C P ^a   Borel Rinkes, Inne H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREDICTION; SCORING SYSTEM; TUMOR GENE;

AGED; AREA UNDER CURVE; COHORT STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK; TREATMENT OUTCOME;

EID: 84869834940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049442     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Mutsaerts EL, van Ruth S, Zoetmulder FA, Rutgers EJ, Hart AA, et al. (2005) Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J Gastrointest Surg 9: 178-186.
3. D'Angelica M, Kornprat P, Gonen M, DeMatteo RP, Fong Y, et al. (2011) Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol 18: 1096-1103.
4. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, et al. (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250: 440-448.
5. Takahashi S, Inoue K, Konishi M, Nakagouri T, Kinoshita T, (2003) Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery 133: 627-634.
6. Crowe PJ, Yang JL, Berney CR, Erskine C, Ham JM, et al. (2001) Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 25: 996-1001.
7. Reissfelder C, Rahbari NN, Koch M, Ulrich A, Pfeilschifter I, et al. (2009) Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol 16: 3279-3288.
8. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824.
9. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
10. Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, et al. (2002) Gene expression in colorectal cancer. Cancer Res 62: 4352-4363.
11. Frederiksen CM, Knudsen S, Laurberg S, Orntoft TF, (2003) Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol 129: 263-271.
12. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22: 1564-1571.
13. Salazar R, Roepman P, Capella G, Moreno V, Simon I, et al. (2011) Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol 29: 17-24.
14. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321.
15. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, et al. (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189: 291-299.
16. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77: 1254-1262.
17. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG, (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135.
18. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, et al. (2007) Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246: 183-191.
19. Lauss M, Ringner M, Hoglund M, (2010) Prediction of stage, grade, and survival in bladder cancer using genome-wide expression data: a validation study. Clin Cancer Res 16: 4421-4433.
20. Subramanian J, Simon R, (2010) Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 102: 464-474.
21. Group TABPW (2004) Expression profiling-best practices for data generation and interpretation in clinical trials. Nat Rev Genet 5: 229-237.
22. van de Peppel J, Kemmeren P, van Bakel H, Radonjic M, van Leenen D, et al. (2003) Monitoring global messenger RNA changes in externally controlled microarray experiments. EMBO Rep 4: 387-393.
23. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, et al. (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15.
24. Margaritis T, Lijnzaad P, van Leenen D, Bouwmeester D, Kemmeren P, et al. (2009) Adaptable gene-specific dye bias correction for two-channel DNA microarrays. Mol Syst Biol 5: 266.
25. Michiels S, Koscielny S, Hill C, (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365: 488-492.
26. Dupont WD, Plummer WD Jr, (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19: 589-601.
27. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-213.
28. Wu H, Kerr MK, Cui XQ, Churchill GA (2003) MAANOVA: a software package for the analysis of spotted cDNA microarray experiments. The analysis of gene expression data: An Overview of methods and software. New York: Springer. 313-431.
29. Hochberg Y, Benjamini Y, (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.